Thursday, 28th March 2024
To guardian.ng
Search
Breaking News:

Innoson awards N3m scholarship to best UTME candidate

By Guardian Nigeria
10 May 2023   |   4:00 am
Innoson Vehicles, a Nigerian automobile manufacturer, founded by Dr Innocent Chukwuma, has awarded a N3 million scholarship to Ejikeme Joy, the overall best-performing candidate in the Unified Tertiary Matriculation Examination (UTME) for the 2023 academic year.

Miss Ejikeme Joy and Dr Innocent Chukwuma

Innoson Vehicles, a Nigerian automobile manufacturer, founded by Dr Innocent Chukwuma, has awarded a N3 million scholarship to Ejikeme Joy, the overall best-performing candidate in the Unified Tertiary Matriculation Examination (UTME) for the 2023 academic year.

Joy, an indigene of Enugu State, but resides in Nnewi with his father an Okada rider, thanked the chairman for the scholarship and promised to make him proud.

A student of Anglican Girls Secondary School in Nnewi, Anambra State, Joy emerged as the overall best student in the 2023 UTME with a score of 362. Joy’s scores in English Language, Physics, Biology, and Chemistry were broken down as 98%, 89%, 94%, and 81%, respectively

This gesture, according to Innoson is not only a celebration of academic excellence but also a reflection of the company’s dedication to investing in the education of young Nigerians. The scholarship will go a long way in providing financial support to Ejikeme Joy, enabling her to pursue her tertiary education with ease in the next five years.

The company’s decision to award the scholarship to the best UTME candidate is a commendable one, as it not only rewards academic excellence but also serves as an inspiration to other students to strive for excellence in their academic pursuits.

The company will continue to demonstrate its commitment to social responsibility through various initiatives, including scholarship awards, job creation, and support for local communities.

This latest scholarship award is a testament to Innoson Vehicles’ dedication to empowering young Nigerians and investing in the future of the nation.

All that said, the results have created real excitement among physicians and people who would be eligible to take what’s being called doxyPEP (for doxycycline post-exposure prophylaxis)—even though health authorities, such as the US Centers for Disease Control and Prevention, haven’t yet made formal recommendations for its use.

“I think this is a real game-changer,” says Paul Adamson, an infectious disease physician and assistant clinical professor of medicine at the University of California, Los Angeles. “We have a huge amount of bacterial STIs in the US. Gay and bisexual men who have sex with men are disproportionately burdened by them. And we have not had a lot of tools that we can use to help.”

0 Comments